Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A

Clinical trial NCT02137850 · COMPLETED

Trial details

NCT number: NCT02137850
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Congenital Bleeding Disorder Haemophilia A

Start date: 2014-06-26
Primary completion: 2023-06-07
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.